Yes, Mr. Ehrlich included more information than was necessary in the NT filing.

To my way of thinking, yes that sends a message.


due to a delay experienced by the Registrant in preparing disclosure relating to recent developments regarding clinical trials for the Registrant’s lead drug compound...